This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jul;76(1):24-26.

doi: 10.1016/j.eururo.2019.01.027. Epub 2019 Feb 1.

Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging Visibility

Jonathan E Shoag¹, Jeffrey J Tosoian², Simpa S Salami², Christopher E Barbieri³

Affiliations

Affiliations

¹ Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA. Electronic address: jes9171@med.cornell.edu.
² Department of Urology, University of Michigan, Ann Arbor, MI, USA.
³ Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA.

PMID: 30712974
DOI: 10.1016/j.eururo.2019.01.027

Editorial

Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging Visibility

Jonathan E Shoag et al. Eur Urol. 2019 Jul.

. 2019 Jul;76(1):24-26.

doi: 10.1016/j.eururo.2019.01.027. Epub 2019 Feb 1.

Authors

Jonathan E Shoag¹, Jeffrey J Tosoian², Simpa S Salami², Christopher E Barbieri³

Affiliations

¹ Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA. Electronic address: jes9171@med.cornell.edu.
² Department of Urology, University of Michigan, Ann Arbor, MI, USA.
³ Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA.

PMID: 30712974
DOI: 10.1016/j.eururo.2019.01.027

No abstract available

PubMed Disclaimer

Comment on

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.
Houlahan KE, Salmasi A, Sadun TY, Pooli A, Felker ER, Livingstone J, Huang V, Raman SS, Ahuja P, Sisk AE Jr, Boutros PC, Reiter RE. Houlahan KE, et al. Eur Urol. 2019 Jul;76(1):18-23. doi: 10.1016/j.eururo.2018.12.036. Epub 2019 Jan 24. Eur Urol. 2019. PMID: 30685078 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information